CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.130
+1.202 (129.43%)
At close: May 12, 2025, 4:00 PM
1.920
-0.210 (-9.86%)
Pre-market: May 13, 2025, 5:17 AM EDT
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $171.72 million as of May 12, 2025. Its market cap has increased by 55.55% in one year.
Market Cap
171.72M
Enterprise Value
99.99M
1-Year Change
55.55%
Ranking
Category
Stock Price
$2.13
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has decreased from $464.70M to $171.72M, a decrease of -63.05%. That is a compound annual growth rate of -9.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 74.30M | -7.82% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 61.78% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |